HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon

This article was originally published in The Rose Sheet

Executive Summary

Direct-seller remains confident business will reach $8.5 bil. by 2007 with 20% operating margin, Exec VP-Asia Pacific, Europe, Middle East & Africa Robert Toth reports during Merrill Lynch Global Branded Consumer Products Conference Oct. 1. Exec says Avon will focus on Central and Eastern Europe as key areas to contribute to growth, highlights Russia as the biggest opportunity in the group. Firm recently announced plans to open $40 mil. manufacturing facility outside Moscow in mid-2004 (1"The Rose Sheet" Sept. 29, 2003, In Brief). Other nations Avon views as strategic regional opportunities include Turkey, Kazakhstan and Bosnia, Toth says...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011553

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel